Transmucosal delivery of peptide derivatives

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 47/48 (2006.01) C07K 7/56 (2006.01) C07K 14/505 (2006.01)

Patent

CA 2611836

What is described is a biological agent, comprised of a biologically active protein, or a fragment or a mimetic thereof, conjugated to at least one poly(alkylene oxide) chain having a size less than about 20 kDa, pharmaceutical formulations for intranasal delivery of said biological agent, or uses of said biological agent in the manufacture of said pharmaceutical formulation for administering said biological agent to a mammal.

La présente invention a trait à un agent biologique, comportant une protéine biologiquement active, ou un fragment ou un agent mimétique de celle-ci, conjuguée à au moins une chaîne poly(oxyde d'alkylène) ayant une taille inférieure à environ 20 kDa, des préparations pharmaceutiques pour l'administration intranasale dudit agent biologique, ou les utilisations dudit agent biologique dans la fabrication de ladite préparation pharmaceutique pour l'administration dudit agent biologique à un mammifère.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Transmucosal delivery of peptide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transmucosal delivery of peptide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transmucosal delivery of peptide derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1747600

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.